Achieve Life Sciences

Our leading investigational drug, cytisinicline, is designed to target nicotine receptors and help reduce: - Nicotine cravings - Withdrawal symptoms - The reward and satisfaction associated with smoking Explore our ongoing research on cytisinicline and its potential to aid in smoking cessation: https://lnkd.in/es52J2zB #SmokingCessation #QuitSmoking #Nicotine 

Achieve Life Sciences is pleased to announce two milestones: - The completion of enrollment for the ORCA-OL Clinical Trial, evaluating the long-term effects of our novel 3mg cytisinicline dosing regimen in individuals who smoke or vape nicotine. - The first Data Safety Monitoring Committee (DSMC) meeting to review the ORCA-OL trial was conducted. The DSMC concluded there are no safety concerns, the overall safety profile appears to be excellent, and the study may proceed as planned with no modifications. Learn more here: https://lnkd.in/eYZ3CXE6 #SmokingCessation #Smoking #Nicotine

Did you know that smoking may increase the risk of vision loss? Smokers are more likely to develop macular degeneration and cataracts, which can lead to blindness. This #BlindnessAwarenessMonth, encourage patients to quit smoking and protect their eyesight. Learn more: https://lnkd.in/exwY5_x6 #QuitSmoking #SmokingCessation #EyeHealth #Nicotine

Our CEO, Rick Stewart, recently spoke with Jamie Ducharme from TIME about the urgent need for dedicated vaping cessation tools. He highlights how Achieve Life Sciences is committed to addressing the vaping addiction crisis, impacting millions who want to quit.   Read the full article: https://lnkd.in/eB2Mft2B   #SmokingCessation #QuitSmoking #VapingCessation #Smokers #Nicotine

Smoking is the leading cause of preventable death, responsible for over 8 million deaths worldwide each year. This includes 1.2 million non-smokers who are impacted by the harmful effects of secondhand smoke. As we continue to address the global smoking health crisis, it’s crucial to raise awareness about the risks and support efforts for smoking cessation. Learn more from the World Health Organization. https://lnkd.in/dP5unx6 #SmokingCessation #Nicotine #QuitSmoking #Smokers

October is #LiverAwarenessMonth— a reminder that smoking impacts nearly every organ, including the liver, increasing the risk of conditions like non-alcoholic fatty liver disease (NAFLD), liver cancer, and cirrhosis. Encourage your patients to quit smoking and support their journey to better liver health. Learn more at the American Liver Foundation: https://lnkd.in/evyFrtp #QuitSmoking #SmokingCessation #LiverHealth #Nicotine

A recent article highlights cytisinicline's potential as an effective tool in combating #smoking dependence, showcasing its role in supporting individuals on their journey to quit.

Exciting news from Achieve Life Sciences! Dr. Mark Rubinstein, a leading expert in nicotine dependence, has been appointed as our new Head of Medical Affairs. With over two decades of experience in clinical medicine, research, and leadership—focused on preventative medicine and #nicotine cessation—we’re confident his expertise will strengthen our #leadership. Learn more: https://lnkd.in/e33ZNGS3

Encourage your patients to embrace Healthy Aging Month by kicking the habit. Quitting smoking is a powerful step towards a longer, healthier life. Smoking can exacerbate health problems like diabetes, lung disease, and bone health. Learn more about the effects of smoking on older adults: https://rb.gy/tt631p #HealthyAgingMonth #SmokingCessation #QuitSmoking #Smokers #Nicotine

On World Lung Day, encourage your patients to breathe new life into their lungs. Quitting smoking can help jumpstart a healthier tomorrow and give their lungs the fresh start they deserve. Learn more about quitting smoking: https://rb.gy/0ppgrf #WorldLungDay #SmokingCessation #QuitSmoking #Smokers #Nicotine